MENU

Shreyas S. Joshi, MD

Dr. Joshi

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Secondary Location

Huntingdon Pike
8 Huntingdon Pike
Rockledge, PA

About

Attending Surgeon

Clinical Instructor

Treatment Focus

Minimally Invasive Surgery
Robotic Surgery
Open surgery
Endoscopic surgery

 

Treatment Philosophy

A cancer diagnosis is a life-changing event, but patients at Fox Chase are not alone when faced with difficult treatment decisions. As a Urologic Oncologist, I help patients navigate these decisions and ensure that they receive the best care possible. 


While I specialize in the surgical management of various cancers—including kidney, bladder, prostate, penile, urethral, ureteral, and testicular—I make sure my patients understand all of their treatment options, including nonsurgical options such as active surveillance. When surgical treatment is necessary, however, I specialize in laparoscopic, robotic, and open surgical approaches, and have extensive training in organ preserving and reconstructive techniques that preserve quality of life.


Because each person is unique, I work with my patients to create an individualized treatment plan that is tailored to their specific needs. Fox Chase Cancer Center provides a distinct culture of excellence in cancer care to help me provide the level of care each patient deserves.

 

Education and Training

Educational Background

  • MPH candidate, Master of Public Health, Temple University College of Public Health, Philadelphia, PA
  • Fellow, Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2016–2018
  • Residency, Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, 2012–16
  • General Surgery Internship, Vanderbilt University Medical Center, Nashville, TN, 2011–12
  • MD, Indiana University School of Medicine, Indianapolis, IN, 2011

Certifications

  • American Board of Urology

Memberships

  • American Urological Association
  • Society of Urologic Oncology

Honors & Awards

  • Alpha Omega Alpha – Inducted 2011
  • Gold Humanism Honor Society – Inducted 2010
  • Dean’s Award – Aiding in matters pertaining to administration and service to the medical community and the School of Medicine. (05/2011)
  • Award of Appreciation – Awarded by the Deans of Indiana University School of Medicine for service as the President of the Medical Student Council (2010)
  • IUSM LCME Nomination – IUSM student nominated for AAMC student position on national LCME board (2010)
  • Certificate of Appreciation – Awarded by the Deans of the Indiana University School of Medicine for service as the Executive Vice President of the Medical Student Council (2009)
  • Phi Beta Kappa of Gamma of Indiana, Indiana University, Bloomington (Inducted 2007)
  • Pi Sigma Alpha – Political Science Honor Society (Inducted 2006)
Research Profile

Research Interests

  • Surgical and disease outcomes for ugologic malignancies
  • Health disparities research
  • The intersection of Public Helath with urologic malignancies
Publications

Selected Publications

Joshi, S. S., Quast, L. L., Chang, S. S. et al.: Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy. Indian Journal of Urology, 34: 68, 2018 PubMed

Correa, A. F., Handorf, E., Joshi, S. S. et al.: Differences in Survival by Receipt of Lymph Node Dissection in Patients with Invasive Penile cancer: Results from the National Cancer Database. Journal of Urology, 2017 PubMed

Shreyas S. Joshi, Elizabeth Handorf, David Strauss, Andres F. Correa, Alexander Kutikov, David Y.T. Chen, Rosalia Viterbo, Richard E. Greenberg, Robert G. Uzzo, Marc C. Smaldone, Daniel M. Geynisman. “Treatment Trends and Outcomes for Lymph Node Positive Penile Cancer Patients.” JAMA Oncology. Accepted – December 2017. PubMed

Shreyas S Joshi, William Sohn, Daniel Sun, Peter E Clark, Daniel A Barocas, Matthew J Resnick, Michael S Cookson, Joseph A Smith and Sam S Chang. “Follow-up imaging in the first two years after nephrectomy for T1 RCC: Over-use or necessary care?” Journal of Clinical Urology. 2016;9(2):105-113.

Joshi S., Sundaram C. “Small Bowel Injury During Laparoendoscopic Single Site Surgery (LESS) for Simple Nephrectomy”. Journal of the Society of Laproendoscopic Surgeons. 2013 Jan-Mar;17(1):167-9.

Steven M Lucas, David Gilley, Shreyas Joshi, and Chandru P Sundaram. “Robotics training program- Evaluation of the satisfaction and the factors that influence success of a resident curriculum at Indiana University”. Journal of Endourology. 2011 Oct;25(10):1669-74.

Zheng, Z., G. Chen, S. Joshi, E. D. Brutinel, T. L. Yahr, and L. Chen. 2007. “Biochemical characterization of a regulatory cascade controlling transcription of the Pseudomonas aeruginosa type III secretion system”. J. Biol. Chem. 282:6136-6142.

Non-Peer-Reviewed Publications

Shreyas Joshi, Alexander Kutikov. Editorial Comment. “Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma.” European Urology Focus. 2016 (In Press)

Shreyas Joshi, David Chen. Editorial Comment. “Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.” Journal of Urology. 2017 Feb; 197(2): 307.

Shreyas Joshi, Alexander Kutikov. Editorial Comment. “Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.” Journal of Urology. 2017 Feb; 197(2): 383-384.

Book Chapters

Shreyas S. Joshi, Robert G. Uzzo. “Renal Tumor Anatomic Complexity; Clinical Implications for Urologists.” Urologic Clinics of North America. 2017 May;44(2):179-187.

Shreyas S. Joshi, Gladell P. Paner, and Sam S. Chang. (2016). “Polycystic Kidney Disease.” The Kidney. New York, NY: Springer Science.

Additional Publications

Dr. Joshi on PubMed

Connect with Fox Chase